EN DE

Swedencare AB (SWDCF) Fair Value & Analysis

Consumer Defensive · US · Market cap $500M

SA Swedencare AB logo Swedencare AB SWDCF · US
Price$2.30
Fair Value$2.81
Upside+22.2%
Quality56/100
Watch Swedencare AB for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 1.8% net margin
Low debt · generates free cash flow
0.97% dividend yield
Trails peers (3/11)
Narrow moat 26/100
Evidence: High Range $1.48 – $3.06 Share as image

Fair value as of: Jul 21, 2026

From 22 valuation models · updated 20 days ago

Fair value updated Jul 21, 2026, revised from $1.65 to $2.81 (+70.4%) since Jun 24, 2026. Share price −26.5% over the past month.

A solid business, screening 22% undervalued on our models.

What matters now

  • Solid quality (56/100) at a price below fair value, the discount is the argument here, not the business quality.
  • A fairly wide model range ($1.48 to $3.06) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$15.64 $2.30 Fair Value $2.81 Jan 2022 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.

How to read this chart

55‑month range $2.30 – $15.64 · fair‑value band $1.48 – $3.06 · the $2.30 price screens below the $2.81 fair value. Dashed = 300-day average. As of Jul 21, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Swedencare AB (SWDCF) currently trades at $2.30, while our model-based Fair Value estimate is $2.81, implying the stock looks roughly 22.2% undervalued today. The Quality Score stands at 56/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Swedencare AB generated revenue of $2.7B at a net margin of 1.8%. Revenue grew 1.4% year over year. It earns a return on equity of 0.7%. Net debt stands at $1.7B. Fundamentals as of Jul 21, 2026

Our scenario range runs from $1.48 (bear case) to $3.06 (bull case); at $2.30, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 51% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 22%, SWDCF screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $11.65 $27.66 $52.83 80
Residual Income $26.61 $23.99 $15.79 76
Rev-Margin DCF $4.18 $13.12 $32.00 74
All 22 models by family
DCF Models
FCF DCF $13.13 $23.92 $56.17 38
Owner Earnings $14.76 $41.69 $91.65 31
5Y Revenue Exit $2.95 $10.14 $24.99 39
5Y EBITDA Exit $17.48 $39.49 $82.65 41
5Y P/E Exit $1.15 $10.07 $21.33 38
10Y Revenue Exit $6.16 $19.92 $26.91 36
10Y EBITDA Exit $16.15 $48.46 $104.77 37
10Y P/E Exit $5.26 $16.38 $32.68 35
Earnings-Based
Graham-Dodd $2.36 $16.47 $23.11 54
Lynch FV $8.51 $12.15 $15.80 50
PEG = 1.0 $8.51 $12.15 $15.80 46
Multiples
P/E Multiple $5.73 $7.64 $9.55 63
P/S Multiple $4.43 $5.90 $7.38 58
P/B Multiple $4.43 $5.90 $7.38 55
EV/EBIT $0.5600 $4.20 $7.83 53
EV/EBITDA $19.04 $28.84 $38.63 54
EV/Revenue $0.7800 $4.11 43
Asset-Based
NCAV (Graham) $20.85 $27.94 $41.70 50
Growth DCF
Growth DCF $11.65 $27.66 $52.83 80
Rev-Margin DCF $4.18 $13.12 $32.00 74
Economic Profit
Residual Income $26.61 $23.99 $15.79 76
Growth Earnings
Growth-Adj P/E $11.29 $16.13 $20.97 68

Widest divergence: Asset-Based ($27.94) versus Multiples ($5.90). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $2.7B
Revenue growth (YoY) +1.4%
Net margin 1.8%
Return on equity 0.7%
Free cash flow $276M FY2025
P/E ratio 104.3
More key figures
EPS (TTM) $0.0300
Dividend yield 1.0%
EPS growth (YoY) -26.4%
Net debt $1.7B FY2025

Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 56/100

Of which business quality 55 · Market factors (momentum, volatility) 20

Profitability 20
Margins and returns on capital today
Quality Growth 54
Are margins and returns improving?
Cashflow 71
Earnings quality: real cash, not paper profit
Fin. Strength 40
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 48
Calm price path (market factor)
Momentum 14
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 74
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Full company description

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products for dogs under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care products, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name. In addition, the company offers dental product for dogs and cats under the ProDen PlaqueOff name; pharmaceutical grade health products for dogs, cats, and horses under the nutravet name; range of products to improve the health and life of pets under the Animal Pharmaceuticals name; dog treat offerings, such as jerky and baked biscuit, as well as nutritional supplements for skin and coat health, ear care, and liver support under the Riley's Organics name; and Rx Vitamins for Pets. The company distributes its products through veterinarians and pet stores, online, veterinary clinics and chains, pharmacy chains, as well as FDMC. Swedencare AB (publ) was incorporated in 1993 and is headquartered in Malmö, Sweden.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Swedencare AB reported revenue of $2.7B in FY2025 versus $770M in FY2021, a compound +36.6%/yr. Reported net income was $55.5M in FY2025, compounding +0.4%/yr from FY2021.

Growth Quality 90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$2.7B
Latest YoY
+6.0%
Avg. growth/yr (3Y)
+13.6%
Avg. growth/yr (5Y)
+62.1%
Avg. growth/yr (11Y)
+53.4%
Revenue +36.6%/yr
FY21 $770M
FY22 $1.8B
FY23 $2.3B
FY24 $2.5B
FY25 $2.7B
Net income +0.4%/yr
FY21 $54.6M
FY22 $94.5M
FY23 $58.6M
FY24 $98.9M
FY25 $55.5M

Watch SWDCF: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Swedencare AB Fair Value". https://www.fairvalue-calculator.com/stock/SWDCF

Peer Group

Packaged Foods · 653 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 56 · Above median
Fair Value upside +22% · Above median
Return on equity (TTM) 1% · Below median
Return on assets 1% · Below median
Net margin (TTM) 2% · Below median
Operating margin (TTM) 0% · Bottom 25%
Revenue growth 1% · Below median
Dividend yield (TTM) 1.0% · Below median
Debt / equity 0.26× · Higher than median

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/E (TTM) 104.3× · Pricier than 75% of peers
P/FCF 1.8× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 63 · sector 29
FUTURE 7 · sector 19
PAST 3 · sector 27
HEALTH 87 · sector 96
DIVIDEND 19 · sector 47

Insider activity: 45/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,427 ₹362.37 -75%
Britannia Industries Limited BRITANNIA ₹5,413 ₹1,870 -65%
Tata Consumer Products Limited TATACONSUM ₹1,089 ₹327.27 -70%
PT Indofood CBP Sukses Makmur Tbk ICBP 6,650 IDR 15,757 IDR +137%
Samyang Foods Co 003230 1,139,000 KRW 1,010,543 KRW -11%
Patanjali Foods Limited PATANJALI ₹413.80 ₹157.04 -62%
Vietnam Dairy Products Joint Stock Company VNM 58,500 VND 68,259 VND +17%
PT Mayora Indah Tbk, MYOR 1,750 IDR 2,699 IDR +54%
PT Cisarua Mountain Dairy Tbk CMRY 4,490 IDR 4,355 IDR -3%
Nongshim Co 004370 348,500 KRW 530,619 KRW +52%

Compare Swedencare AB with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Swedencare AB (SWDCF) overvalued or undervalued?
As of Jul 21, 2026, our model estimates a fair value of $2.81 versus a price of $2.30, about +22% (undervalued).
What is the fair value of SWDCF?
Our model-based fair value for Swedencare AB is $2.81 (as of Jul 21, 2026), built from audited fundamentals. The current price is $2.30.
What is the quality score of SWDCF?
Swedencare AB has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Swedencare AB (SWDCF)?
Swedencare AB reported trailing-twelve-month revenue of about $2.7B (latest available figure, as of Jul 21, 2026).
What is the net profit margin of SWDCF?
The net profit margin of Swedencare AB is about 1.8%, meaning it keeps roughly 1.8% of revenue as net income. Based on the latest reported figures.
Does Swedencare AB pay a dividend?
Swedencare AB currently shows a dividend yield of about 0.97% relative to its recent price (as of Jul 21, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Swedencare AB and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.